Separation of β-amyloid binding and white matter uptake of (18)F-flutemetamol using spectral analysis.
暂无分享,去创建一个
Koen Van Laere | Mark Lubberink | Kerstin Heurling | Rik Vandenberghe | M. Lubberink | R. Vandenberghe | K. Laere | C. Buckley | K. Heurling | Christopher Buckley
[1] J. Anderson. A rapid and accurate method to realign PET scans utilizing image edge information. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] S. Lehéricy,et al. Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl‐11C]‐2‐(4′‐methylaminophenyl)‐ 6‐hydroxybenzothiazole , 2011, Annals of neurology.
[3] Ranjan Duara,et al. Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density. , 2015, JAMA neurology.
[4] M. Leon,et al. Reduced retention of Pittsburgh compound B in white matter lesions , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[5] S. DeKosky,et al. Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] Vincent J. Cunningham,et al. Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model , 1997, NeuroImage.
[7] Mattia Veronese,et al. Quantification of [11C]PIB PET for Imaging Myelin in the Human Brain: A Test—Retest Reproducibility Study in High-Resolution Research Tomography , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] T. Jones,et al. Spectral Analysis of Dynamic PET Studies , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[9] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[10] Jerry L Prince,et al. Measurement of Radiotracer Concentration in Brain Gray Matter Using Positron Emission Tomography: MRI-Based Correction for Partial Volume Effects , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] E. Salmon,et al. 18F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial , 2010, Annals of neurology.
[12] G Lucignani,et al. Estimation of Component and Parameter Distributions in Spectral Analysis , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[13] Chris Buckley,et al. Parametric imaging and quantitative analysis of the PET amyloid ligand [18F]flutemetamol , 2015, NeuroImage.
[14] R. Vandenberghe,et al. Whole-Body Biodistribution and Radiation Dosimetry of 18F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging , 2009, Journal of Nuclear Medicine.
[15] L. Thurfjell,et al. Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease , 2009, Journal of Nuclear Medicine.
[16] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[17] Olaf B. Paulson,et al. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps , 2005, NeuroImage.
[18] M. Modat,et al. The importance of appropriate partial volume correction for PET quantification in Alzheimer’s disease , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[19] C. Rowe,et al. Characterization of PiB Binding to White Matter in Alzheimer Disease and Other Dementias , 2009, Journal of Nuclear Medicine.
[20] Paul Edison,et al. Strategies for the generation of parametric images of [11C]PIB with plasma input functions considering discriminations and reproducibility , 2009, NeuroImage.
[21] F. Turkheimer,et al. The Use of Spectral Analysis to Determine Regional Cerebral Glucose Utilization with Positron Emission Tomography and [18F]Fluorodeoxyglucose: Theory, Implementation, and Optimization Procedures , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] S. Hatashita,et al. [18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer’s disease , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[23] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.